Sansure Biotech Inc.

Home
China
Changsha
Sansure Biotech Inc.

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Sansure Biotech Inc., Biotechnology company, No. 680 Lusong Road, Changsha.

Sansure Biotech Inc., a listed company in China, is a comprehensive provider of integrated diagnosis and treatment solutions, with independent and innovative gene technology at its core

14/08/2026

From Global Health Goals to Sansure Diagnostic Action.

The WHO's 2022–2030 Global Health Sector Strategies call for accelerated action to end AIDS, viral hepatitis and sexually transmitted infections as public health threats by 2030 — through integrated, people-centred services, expanded access and innovation.

At , we are turning these priorities into diagnostic action with an integrated molecular diagnostic ecosystem — combining a comprehensive testing portfolio with scalable automated platforms to support , viral and testing across diverse healthcare settings.

From high-throughput automated testing in central laboratories to decentralized molecular testing closer to the point of need, our solutions are designed to support earlier detection, expand testing capacity and make quality diagnostics more accessible. Sansure's portfolio spans fully automated systems, extraction platforms, instruments and molecular solutions.

Advancing Diagnostics. Expanding Access.Let's Moving Together Towards 2030.

Read more about WHO strategies: who.int/publications/i/item/9789240053779

06/08/2026

Sansure Brand‑New APAC & MEA Linkedin Accounts | Live Now! 📢

We're thrilled to introduce two brand‑new regional Showcase Pages — designed to bring you closer to what's happening on the ground and advance Sansure's global footprint across key growth markets.

Alongside our global corporate channel, these dedicated regional hubs deliver content tailored specifically for our local partners — from regulatory insights and customer success stories to market initiatives, workshop recaps, product launches, and upcoming industry events — all with a local lens.

✅Sansure Biotech APAC
🔗 https://linkedin.com/showcase/sansure-biotech-apac
Built for partners across Asia, covering Thailand, Indonesia, Vietnam and many more APAC markets. Follow for region‑relevant insights and local activity highlights.

✅Sansure Biotech MEA
🔗 https://linkedin.com/showcase/sansure-biotech-mea
Dedicated to the Middle East and Africa community, featuring local market intelligence, event recaps and key business updates.

As we continue expanding our global presence, these regional pages serve as our local touchpoints to connect, share market intelligence and support partners worldwide.

We warmly invite you to follow both pages to catch timely, location‑specific news from Sansure Biotech.

05/08/2026

Breaking news!🎉

Sansure Biotech has obtained CE-IVDR certification for 5 molecular diagnostic products, covering IVDR Class C & Class D full-risk portfolios.

✅2 × IVDR Class C
‑ HPV Genotyping Kit
‑ SARS‑CoV‑2, Flu A/B & RSV 4‑in‑1 Diagnostic Kit

✅3 × IVDR Class D (Highest‑risk category)
‑ HIV‑1, HBV, HCV Fluorescence Quantitative Diagnostic Kits

This milestone fully validates our R&D, production and quality systems against the EU's strictest IVD regulations. Very few Chinese manufacturers have achieved full IVDR compliance across cervical screening, respiratory testing, and blood-borne pathogen screening.

These globally recognized qualifications further strengthen our overseas market layout, empowering reliable and accessible molecular diagnostic solutions for global public health.

👉 Swipe left to explore the five products.

28/07/2026

287 𝑚𝑖𝑙𝑙𝑖𝑜𝑛 𝑝𝑒𝑜𝑝𝑙𝑒 𝑤𝑒𝑟𝑒 𝑙𝑖𝑣𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑐ℎ𝑟𝑜𝑛𝑖𝑐ℎ𝑒𝑝𝑎𝑡𝑖𝑡𝑖𝑠 𝐵 𝑜𝑟 𝐶 𝑖𝑛 2024.
𝑂𝑛𝑙𝑦 45% 𝑜𝑓 𝑏𝑎𝑏𝑖𝑒𝑠 𝑟𝑒𝑐𝑒𝑖𝑣𝑒𝑑 𝑡ℎ𝑒 ℎ𝑒𝑝𝑎𝑡𝑖𝑡𝑖𝑠 𝐵 𝑣𝑎𝑐𝑐𝑖𝑛𝑒 𝑤𝑖𝑡ℎ𝑖𝑛 24 ℎ𝑜𝑢𝑟𝑠 𝑜𝑓 𝑏𝑖𝑟𝑡ℎ 𝑖𝑛 2024
1.3 𝑚𝑖𝑙𝑙𝑖𝑜𝑛 𝑝𝑒𝑜𝑝𝑙𝑒 𝑑𝑖𝑒𝑑 𝑜𝑓 𝑐ℎ𝑟𝑜𝑛𝑖𝑐 ℎ𝑒𝑝𝑎𝑡𝑖𝑡𝑖𝑠 𝐵 𝑎𝑛𝑑 𝐶 𝑖𝑛 2024*

Today is World Hepatitis Day.

Despite continued progress, millions of people remain undiagnosed or unable to access timely treatment and care.

Low viral loads and occult infections can complicate detection and ongoing disease management, underscoring the importance of reliable and accessible molecular testing.

At Biotech, we provide standardized hepatitis molecular testing solutions across multiple diagnostic platforms, supporting key clinical needs throughout the disease-management pathway:
✅ Confirmation of active infection
✅ Support for informed treatment decisions
✅ Long-term follow-up and therapeutic monitoring
✅ Evaluation of treatment response and endpoints

Accessible, high-quality molecular diagnostics, together with effective treatment, are essential to enabling earlier intervention and improving patient outcomes.

This World Hepatitis Day, let us break down the barriers to testing, treatment and care—and accelerate progress toward eliminating viral hepatitis as a public health threat by 2030.

*Data Source: https://www.emro.who.int/world-hepatitis-day/2026/index.html

27/07/2026

🏆 Big news: 4 major legal awards for Sansure!

We are proud to announce that Sansure has secured four honors at China Business Law Journal's 2026 Enterprise Legal Awards, including:

1️⃣Biomedical & life sciences — Legal Team of the Year (Winner)
2️⃣Biomedical & life sciences — Outstanding Legal Team (Highly commended)
3️⃣Cross-border Compliance — Outstanding Legal Team (Highly commended)
4️⃣Cross-border Compliance — Legal Service Award (Highly commended)

As a highly authoritative benchmark for corporate legal excellence across Asia, CBLJ's awards adopt strict, multi-dimensional evaluation standards. Winning recognition in both heavily regulated life sciences and cross-border compliance fields validates our robust legal governance, full-lifecycle compliance management, IP protection and global risk control strengths.
Over the past year, we have upgraded our legal system from passive risk response to proactive governance, supporting our global expansion across Europe, North America, Southeast Asia and continuous technological innovation.

Moving forward, we will keep embedding rigorous compliance into every link of our worldwide operations, delivering responsible, sustainable growth as a Chinese life sciences enterprise.

08/07/2026

Opening Day Highlights | Sansure at WHX Bangkok 2026 🚀

What an incredible first day! Our booth was buzzing with non-stop energy, and our team had inspiring, in-depth conversations with partners, clinicians, and industry experts from across the globe.

The response to our three core solution portfolios was overwhelming — and we’re proud to showcase:

🏥 High-Throughput Lab Automation
💡 Flexible Clinical Innovation
🩺 Compact Primary Care "Mini Labs"

But this is just the beginning — we still have two full days to go!

Our experts are on-site and ready to explore partnership opportunities with you. Don’t miss the chance to see our integrated diagnosis & treatment solutions in action.

📍 Booth H07·M02 | Until July 10

05/07/2026

⏳ 𝟑 𝐃𝐀𝐘𝐒 𝐓𝐎 𝐖𝐇𝐗 𝐁𝐀𝐍𝐆𝐊𝐎𝐊 𝟐𝟎𝟐𝟔!

is ready to showcase our integrated diagnosis & treatment solutions at Booth H07·M02, Queen Sirikit National Convention Center.

Our experts look forward to in-depth discussions with you during July 8–10. See you in Bangkok!

28/06/2026

WHX Bangkok is almost here! Are you ready to explore the future of integrated healthcare?😊

We’re excited to unveil Sansure’s latest clinical diagnosis and treatment solutions — and to make your visit easier, we’ve tailored our breakthrough technologies into three distinct, real-world application scenarios.

1️⃣ Laboratory Scenario: High-Throughput Automation
Say goodbye to manual bottlenecks. Discover how we integrate automation and intelligence to maximize lab efficiency:
🔹 Natch CS3 Plus – Fully automated nucleic acid processing system for seamless, high-capacity workflows.
🔹 SLAN-48S – Real-time PCR system with advanced 8-channel fluorescence detection for exceptional precision.

2️⃣ Innovation Scenario: Flexible & Patient-Centric Tech
Explore versatile solutions designed to adapt to diverse clinical needs and elevate patient care:
🔹 SUREXEVO – Fully automated, integrated nucleic acid analyzer.
🔹 Q-POC (by QuantuMDX) – Portable DNA/RNA analyzer enabling rapid, decentralized molecular testing.
🔹 hGH (by Hygene) – Human growth hormone injection paired with an electronic auto-injector for optimized, intelligent delivery.

3️⃣ Primary Care Scenario: The Miniature Lab
Experience full testing capabilities packed into ultra-compact, portable spaces — ideal for frontline healthcare:
🔹 iPonatic Ⅲ – Portable molecular workstation with scalable wireless networking (supports up to 8 devices).
🔹 iMC Ge52e (by Hongan) – Automatic hematology analyzer designed for improved precision and reproducibility in routine workflows.
🔹 NIR-1000 (by WWHS) – Dry fluoroimmunoassay analyzer using near-infrared technology for rapid, high-sensitivity testing.

Come by our booth, meet our experts, and explore new partnership opportunities. Let’s connect in Bangkok!

Learn more: www.sansureglobal.com

27/06/2026

𝟏 𝐝𝐞𝐚𝐭𝐡 𝐞𝐯𝐞𝐫𝐲 𝟗𝟎 𝐬𝐞𝐜𝐨𝐧𝐝𝐬.

That’s the reality of cervical cancer—349,000 lives lost in 2022 alone, alongside 662,000 new cases diagnosed that same year.

To change this, the WHO Global Strategy sets a clear target: screen 70% of women with a high-performance test by age 35, and again by age 45.

The 2026 WHO guideline reinforces HPV DNA testing as the primary screening method for the general female population—and underscores the power of genotype-based risk stratification.

Under this framework, 12 carcinogenic HPV types are classified into four risk groups (1a–1d). By incorporating limited or extended genotyping, laboratories gain a built-in molecular triage approach that enables straightforward risk stratification and prioritized clinical management for HPV-positive women.

At Sansure, our comprehensive HPV portfolio aligns with these 12 WHO-defined high-risk types—covering the entire workflow from sample collection and nucleic acid processing to amplification and multi-scenario testing.

We support diverse clinical settings:
✅ High-throughput central labs
✅ Routine molecular diagnostics
✅ Point-of-care testing
✅ Both clinician-collected and self-collected samples

Our goal? To make cervical cancer screening more efficient, accessible, and scalable—across every region, every setting.

Together, let’s advance standardized HPV screening and drive progress toward a world free of cervical cancer.

Learn more: www.sansureglobal.com

Address

No. 680 Lusong Road
Changsha
410205

Website

http://www.sansureglobal.com/

Alerts

Be the first to know and let us send you an email when Sansure Biotech Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sansure Biotech Inc.:

Want your business to be the top-listed business in Changsha?